These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2732517)

  • 41. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
    Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
    Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative merits of partial splenectomy, splenic reimplantation, and immunization in preventing postsplenectomy infection.
    Cooney DR; Dearth JC; Swanson SE; Dewanjee MK; Telander RL
    Surgery; 1979 Oct; 86(4):561-9. PubMed ID: 39355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved antibody responses to delayed pneumococcal vaccination in splenectomized rats.
    Werner AM; Solis MM; Vogel R; Southerland SS; Ashley AV; Floyd JC; Brown C; Ashley DW
    Am Surg; 1999 Sep; 65(9):844-7; discussion 847-8. PubMed ID: 10484087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency.
    Schenkein JG; Park S; Nahm MH
    Vaccine; 2008 Oct; 26(43):5521-6. PubMed ID: 18706464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of partial splenectomy on experimental pneumococcal bacteremia in an animal model.
    Okinaga K; Giebink GS; Rich RH; Baesl TJ; Krishnanaik D; Leonard AS
    J Pediatr Surg; 1981 Oct; 16(5):717-24. PubMed ID: 7310607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
    Lue C; Tarkowski A; Mestecky J
    J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
    Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
    Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Wang Y; Wen Z; Pan X; Briles DE; He Y; Zhang JR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.
    Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH
    Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes.
    Leemans R; Manson W; Snijder JA; Smit JW; Klasen HJ; The TH; Timens W
    Ann Surg; 1999 Feb; 229(2):279-85. PubMed ID: 10024111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.
    Musher DM; Luchi MJ; Watson DA; Hamilton R; Baughn RE
    J Infect Dis; 1990 Apr; 161(4):728-35. PubMed ID: 2319166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody responses to pneumococcal and hemophilus vaccinations in splenectomized patients with hematological malignancies or trauma.
    Eigenberger K; Sillaber C; Greitbauer M; Herkner H; Wolf H; Graninger W; Gattringer R; Burgmann H
    Wien Klin Wochenschr; 2007; 119(7-8):228-34. PubMed ID: 17492350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine.
    Musher DM; Ceasar H; Kojic EM; Musher BL; Gathe JC; Romero-Steiner S; White AC
    J Infect Dis; 2005 Apr; 191(7):1063-7. PubMed ID: 15747240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of antibody levels and protective efficacy against pneumococci in two immunoglobulin preparations for intravenous use.
    Offenbartl K; Gullstrand P; Prellner K; Christensen P; Henrichsen J
    Int Arch Allergy Appl Immunol; 1986; 80(3):307-11. PubMed ID: 3087886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
    Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination.
    Pedersen FK; Nielsen JL; Ellegaard J
    Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):245-9. PubMed ID: 6637480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of protection by pneumococcal vaccine after splenectomy in mice challenged with aerosolized pneumococci.
    Hebert JC; Gamelli RL; Dickerman JD; Chalmer BJ; Gump DW; Foster RS
    J Trauma; 1983 Jan; 23(1):1-6. PubMed ID: 6822995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of effect of splenic regrowth on the reduced antibody responses to pneumococcal polysaccharides in splenectomized patients.
    Kiroff GK; Hodgen AN; Drew PA; Jamieson GG
    Clin Exp Immunol; 1985 Oct; 62(1):48-56. PubMed ID: 4064376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease.
    Mahmoodi M; Aghamohammadi A; Rezaei N; Lessan-Pezeshki M; Pourmand G; Mohagheghi MA; Abdollahzade S; Mousavi-Jarrahi A
    Eur Cytokine Netw; 2009 Jun; 20(2):69-74. PubMed ID: 19541592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Fluosol DA 20% on antibody response to type 3 pneumococcal polysaccharide in rats.
    Molina NC; Hodges GR; Worley SE; Abdou NI
    Clin Immunol Immunopathol; 1987 Feb; 42(2):211-7. PubMed ID: 3802584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.